China – Pathfinder™ cell Reader- Analyzer

With the additional set-up of 6 to 20 Pathfinder™ CTC Cell Reader-Analyzers, we strengthen our presence in China, and the recognition of our innovative technology in liquid biopsy accurate testing, allowing CTCs and CTMs counting and characterization. The introduction of automated, effective and low-cost cellular CTC test could allow, at large-scale, assistance to medical decision in lung, breast and colon cancer.